MASERU – Halo Collective, a cannabis company that owns Bophelo Bioscience and Wellness in Lesotho, has achieved the European Union Good Agricultural and Collection Practices (EU GACP) compliance, clearing the way for commercial export of medical cannabis. The EU GACP certification was awarded to Bophelo by Pharmaconsulta Ltd, an independent consultancy firm based in Malta specialising in pharmaceutical regulatory affairs.
Pharmaconsulta’s audits are recognised globally. The EU GACP certification enables Bophelo to enter the international medical cannabis supply chain, including the European Union (EU) market. The EU medical cannabis market was predicted would be worth approximately $37 billion (about M536.5 billion) by 2027 according to Prohibition Partners, a leading market intelligence firm providing strategic consultancy services in the global cannabis industry.
Halo Collective is a leading, vertically integrated cannabis company that cultivates, extracts, manufactures and distributes quality cannabis flower, oils and concentrates. The company has sold approximately nine million grams of oils and concentrates since inception. It continues to expand its business and scale efficiently, partnering with trustworthy leaders in the industry who value its operational expertise in bringing top-tier products to the market.
The company announced recently that it has received certification for cannabis growth at Bophelo’s initial 14-hectare cultivation site, scalable up to 200ha, located in Tšakholo, Mafeteng. “EU GACP certification is a hard-won accomplishment that enables Bophelo to participate in the large, rapidly growing market in the EU for medical cannabis. With this approval, Bophelo can begin commercialising its California and Oregon West Coast style cannabis for the EU immediately,” the Chief Executive Officer and Co-Founder of Halo Collective, Kiran Sidhu said.
In addition, he said, Bophelo is actively working to secure distributors for its premium flower lines. The firm operates a campus in Lesotho focused on the cultivation and production of medical cannabis products for international export. It is one of the largest licenced marijuana cultivation sites in the world with access to a maximum of 200 hectares of canopy. Halo Collective currently operates in the United States in Oregon and California, Canada, Lesotho and the United Kingdom (UK).
The company recently announced its intention to reorganise its non-US operations into a newly formed entity called Akanda Corp, whose mission will be to provide high quality and ethically sourced medical cannabis products patients worldwide.
Mr Sidhu will seek to deliver on this promise while driving positive change in wellness, empowering individuals in Lesotho, and uplifting the quality of the lives of the employees and the local communities where the company operates, while limiting its carbon footprint.
He will also combine the scaled production capabilities of Bophelo Bioscience and wellness, Halo’s Lesotho based cultivation and processing campus located in the world’s first Special Economic Zone (SEZ) containing cannabis cultivation operation, with distribution and route-to-market efficiency of Halo’s UK based fully approved pharmaceutical importer, Canmart.